124-iodine-labeled PSCA targeting minibody (ImaginAb)

N/A

Report date: 2025/11/21 17:16:18

Base Information

Drug Name124-iodine-labeled PSCA targeting minibody (ImaginAb)

Drug Alias Name124-iodine-labeled prostate stem cell antigen-targeting minibody (prostate/bladder/pancreatic cancer)I-124-Cys-Db124-iodine-labeled PSCA targeting diabody (cancer)I-124-Mb

ClassificationBiologicsDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agent +[6]

Mechanisms of ActionProstate stem cell antigen inhibitors

TargetsProstate stem cell antigen

Therapy Area/IndicationsUrinary Bladder NeoplasmsProstatic NeoplasmsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of California At Los Angeles

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California At Los Angeles Imaginab Inc

Inactive CompaniesN/A

Active IndicationsUrinary Bladder NeoplasmsProstatic NeoplasmsPancreatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A